Help enable lifesaving research to change the course of COVID-19

The Kirby Institute at UNSW Sydney has over 30 years of infectious disease expertise, and we have a strong track record of developing solutions to infectious diseases that can be scaled for maximum impact across diverse communities and populations.

Our scientists and researchers are utilising this expertise, working around the clock to develop lifesaving treatments and therapies to manage COVID-19. This research, conducted as part of the global research effort, will be critical to changing the course of COVID-19.

This end of financial year, we’re seeking your support to boost and fast-track our COVID-19 research.

We are developing innovative immunotherapy solutions to boost immunity and reduce the prevalence and severity of COVID-19, with a particular focus on vulnerable people such as frontline healthcare workers, the elderly and those with compromised immune systems.

By harnessing antibodies, the Kirby Institute is working to develop an effective treatment for affected patients and fast-track a solution to COVID-19. Kirby Institute researchers are also working on strategies to optimise the ways of delivering treatments efficiently to the appropriate cells in the body’s immune system.

“We have highly experienced teams, cutting-edge equipment, and a track record of uncovering the answers that save lives,” says Professor Anthony Kelleher, Director of the Kirby Institute. “With this expertise, and with our extensive clinical trials networks, we are fast-tracking this promising research, to ensure that these treatments get into the hands of those who need them most.”

This is just one of the ways in which the Kirby Institute has transformed to bring our knowledge, experience and collaborative networks to support the global efforts to control COVID-19.

Your support will help ensure that we can have the rapid impact needed to save lives in the fight against COVID-19.

You can read more about our COVID-19 research here.

Date published: 
Monday, 22 June 2020
Abel Orellana